Original document(22 pages) Authorized document(16 pages) 中文版
    The present invention discloses an anti-SARS specific IgY, its preparation method and its preparation. Said preparation method includes the following steps: screening out main pathogenic virus resulted in SARS disease, on the basis of screening and differential combinations respectively preparing single or complex pathogenic virus antigens, preparing immunoprotein and preparing anti-SARS various pathogenic virus specific IgY crude extracts and purifying the above-mentioned crude extracts which can be made into several preparations for preventing and curing SARS.
Application Number
申请号
03136101 Application Date
申请日
2003.05.13
Title 名称 Anti SARS specificity IgY and combination preparation thereof
Publication Number
公开号
1450086 Publication Date
公开日
2003.10.22
Approval Pub. Date 2007.05.30 Granted Pub. Date 2007.05.30
International Classification 分类号 C07K16/08;C12N7/00;A61K39/395;A61P31/14
Applicant(s) Name
申请人
Yachen Pharmaceutical Ind (Far East) Co., Ltd.
Address 地址
Inventor(s) Name 发明人 Bao Cheng
Attorney & Agent 代理人 liu xiaomin

  
Safety toothpaste for preventing and curing oral cavity disease
Antipyrotic mouth wash or oral piece for preventing caries
Anti-sphagitis specificity composite IgY and preparation thereof
Rhinitis and nasosinusitis resisting specific IgY and its combined preparation
Gynaecological anti-infective specificity IgY and its combined preparation
Production method of specific IgY for venereal disease and its combined preparation
Specific IgY and composite IgY for Rheum and its novel formulation
Method for preparing specific composite IgY against periodontal disease and group system thereof
Preparation method of specific IgY for resisting respiratory tract infection and its compound preparation
Anti irritability Specificity Igy and its preparation
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.